Cleared Traditional

K860049 - DETERMINATION OF QUINIDINE

K860049 is the FDA 510(k) clearance for DETERMINATION OF QUINIDINE by Clinical Data, Inc.. It is a Class 2 Toxicology device (product code LBZ) cleared through the Traditional 510(k) pathway after a 16-day FDA review.

K860049 · Clinical Data, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1986
Decision
16d
Days
Class 2
Risk

K860049 is an FDA 510(k) clearance for the DETERMINATION OF QUINIDINE. Classified as Enzyme Immunoassay, Quinidine (product code LBZ), Class II - Special Controls.

Submitted by Clinical Data, Inc. (Boston, US). The FDA issued a Cleared decision on January 22, 1986 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3320 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Clinical Data, Inc. devices

Submission Details

510(k) Number K860049 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 1986
Decision Date January 22, 1986
Days to Decision 16 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 87d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LBZ Enzyme Immunoassay, Quinidine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - LBZ Enzyme Immunoassay, Quinidine

All 20
Devices cleared under the same product code (LBZ) and FDA review panel - the closest regulatory comparables to K860049.
TDXR FLECAINIDE
K872175 · Abbott Laboratories · Aug 1987
EASY-TEST QUINIDINE ITEM NO. 67---/95
K864607 · Em Diagnostic Systems, Inc. · Jan 1987
EMIT QUINIDINE ASSAY
K862214 · Syva Co. · Jun 1986
COBAS FP REAGENTS FOR QUINIDINE
K850808 · Roche Diagnostic Systems, Inc. · Mar 1985
STRATUS QUINIDINE FLUOROMETRIC ENZYME
K843237 · American Dade · Sep 1984
TDX DISOPYRAMIDE
K842713 · Abbott Laboratories · Aug 1984